Resect and Discard Extension to FICE of NIcE Classification

NCT ID: NCT02263144

Last Updated: 2014-10-13

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

110 participants

Study Classification

OBSERVATIONAL

Study Start Date

2014-05-31

Study Completion Date

2014-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this prospective, non-interventional study is to validate the Narrow Band Imaging International Colorectal Endoscopic (NICE) classification for differentiating subcentimetric hyperplastic and adenomatous polyps by using Fuji Intelligent Color Enhancement (FICE) technology with high-definition without optical magnification.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

1. In order to create a video-library of endoscopic cases, patients undergoing screening or diagnostic colonoscopy will be considered for inclusion. Patients with at least one histologically verified \<10 mm polyp will be included. A short video-clip (around 15-20 seconds) of each polyp both at white-light and FICE-light will be recorded and stored in an anonymized database.
2. Once the video-library is completed, each of 7 experts will independently review all the cases. For each case, any observer will assess each of the three NICE criteria (colour/vascularization/surface), the degree of confidence (low/high), and classify the lesion as neoplastic or non-neoplastic. The primary outcomes are the accuracy of FICE technology with high-definition and without magnification, when adopting NICE classification, to differentiate between hyperplastic and adenomatous lesions, and the inter-observer agreement in such differentiation. Secondary end-points are to assess at multivariate measure the role of any individual criteria of NICE classification in the discrimination between the two histotypes, and possible adaptations of NICE classification in order to be applied with FICE.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hyperplastic Polyps Adenomatous Polyps

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

histologically-verified <10mm polyps

histologically-verified \<10mm polyps, analyzed by virtual chromo-endoscopy using FICE Fujifilm Technology

virtual chromo-endoscopy using FICE Fujifilm Technology

Intervention Type PROCEDURE

For each polyps, any observer will use virtual chromo-endoscopy with FICE Fujifilm Technology

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

virtual chromo-endoscopy using FICE Fujifilm Technology

For each polyps, any observer will use virtual chromo-endoscopy with FICE Fujifilm Technology

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. The patient is undergoing colonoscopy for screening, for surveillance in follow-up of previous polypectomy or for diagnostic work-up;
2. The patient is at satisfactory risk to undergo abdominal surgery;
3. The patient must understand and provide written consent for the procedure.

Exclusion Criteria

1. Patients with inflammatory bowel disease;
2. Patients with a personal history of polyposis syndrome;
3. Patients with diverticulitis or toxic megacolon;
4. Patients with a history of radiation therapy to abdomen or pelvis.
5. Patients with a history of severe cardiovascular, pulmonary, liver or renal disease;
6. Personal history of coagulation disorders or use of anticoagulants
7. Patients who are currently enrolled in another clinical investigation in which the intervention might compromise the safety of the patient's participation in this study.
Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Universitaire Ziekenhuizen KU Leuven

OTHER

Sponsor Role collaborator

Royal Alexandra Hospital

OTHER

Sponsor Role collaborator

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

OTHER

Sponsor Role collaborator

Nuovo Regina Margherita Hospital

OTHER

Sponsor Role collaborator

University of Erlangen-Nürnberg Medical School

OTHER

Sponsor Role collaborator

University Hospital Regensburg

OTHER

Sponsor Role collaborator

Hôpital Edouard Herriot

OTHER

Sponsor Role collaborator

Istituto Clinico Humanitas

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Michele Tedeschi

Responsabile Progetto Ricerca Clinica

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Alessandro Repici, MD

Role: PRINCIPAL_INVESTIGATOR

Istituto Clinico Humanitas

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Dept of Gastroenterology and Endoscopy, University Hospital

Leuven, , Belgium

Site Status RECRUITING

Dept of Gastroenterology, Edouard Herriot Hospital, Hospices Civils of Lyon

Lyon, , France

Site Status RECRUITING

Department of Medicine I, University of Erlangen-Nürnberg Medical School

Erlangen, , Germany

Site Status RECRUITING

Dept of Gastroenterology and interventional Endoscopy, Krankenhaus Barmherzige Brüder

Regensburg, , Germany

Site Status RECRUITING

Endoscopy Unit, Humanitas Research Hospital

Rozzano, Milano, Italy

Site Status RECRUITING

Digestive Endoscopy Unit, Nuovo Regina Margherita Hospital

Rome, , Italy

Site Status RECRUITING

Solent Centre for Digestive Diseases , Royal Alexandra Hospital

Portsmouth, , United Kingdom

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Belgium France Germany Italy United Kingdom

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Alessandro Repici, MD

Role: CONTACT

+39282247493

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Raf Bisschops, MD

Role: primary

Thierry Ponchon, MD

Role: primary

Helmut Neumann, MD

Role: primary

Oliver Pech, MD

Role: primary

Alessandro Repici, MD

Role: primary

+39282247493

Cesare Hassan, MD

Role: primary

Pradeep Bhandari, MD

Role: primary

References

Explore related publications, articles, or registry entries linked to this study.

Hewett DG, Kaltenbach T, Sano Y, Tanaka S, Saunders BP, Ponchon T, Soetikno R, Rex DK. Validation of a simple classification system for endoscopic diagnosis of small colorectal polyps using narrow-band imaging. Gastroenterology. 2012 Sep;143(3):599-607.e1. doi: 10.1053/j.gastro.2012.05.006. Epub 2012 May 15.

Reference Type BACKGROUND
PMID: 22609383 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

REDEFINE

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

AI Colorectal Polyp Detection
NCT04979962 COMPLETED NA